Association Between African American Race, Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 3, 2020

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17020?guestAccessKey=73e60ed2-a471-42c9-88e6-f9ea3cf29089&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110320

 

What The Study Did: This observational study estimates the 10-year risk for disease progression, surgery, metastasis, and cause-specific and all-cause mortality among African American men with low-risk prostate cancer managed with active surveillance.

Authors: Brent S. Rose, M.D., of the VHA San Diego Health Care System and the University of California San Diego School of Medicine in La Jolla, California, is the corresponding author.

 

(doi:10.1001/jama.2020.17020)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.